In vitro antiproliferative effect of trastuzumab (Herceptin®) combined with cetuximab (Erbitux®) in a model of human non-small cell lung cancer expressing EGFR and HER2
Crossref DOI link: https://doi.org/10.1007/s10238-015-0343-8
Published Online: 2015-02-26
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Privitera, G.
Luca, T.
Musso, N.
Vancheri, C.
Crimi, N.
Barresi, V.
Condorelli, D.
Castorina, S.
Text and Data Mining valid from 2015-02-26